-
Vireo Q1 Revenue Increases 9% YoY, Reports Improvement In Gross Margin
Friday, May 14, 2021 - 11:27am | 432Vireo Health International, Inc. (CSE: VREO) (OTCQX: VREOF), a science-focused, multistate cannabis company, reported its financial results for the first quarter of 2021 on Friday. The Minneapolis-based company generated $13.2 million in GAAP revenue for the first three months of 2021,...
-
Vireo Launches Its First Line Of Ground Medical Cannabis Flower In New York
Thursday, April 29, 2021 - 12:50pm | 371Vireo Health International, Inc. (CSE: VREO) (OTCQX: VREOF) is introducing its first line of ground medical cannabis flower in New York. The new product, expanded to include four strains, will be available at all four of Vireo's New York-based retail locations as well as via home...
-
Vireo Health, Arizona Natural Remedies Expand Cultivation Facility To Create 45 New Jobs
Thursday, February 18, 2021 - 1:57pm | 300Vireo Health International, Inc. (CNSX: VREO) (OTCQX: VREOF) confirmed Thursday that its partner, Arizona Natural Remedies Inc., has finalized a grand expansion of its cultivation and processing facility. The facility, located south of Tuscon, now has a nine-acre shade house, which is expected...
-
Cannabis Movers & Shakers: Radiant Ventures, Vireo Health, Aurora Cannabis, 14th Round, Surna
Tuesday, June 30, 2020 - 3:21pm | 1251As we are wrap up a busy June, let's take a look at the recent leadership changes in the cannabis industry. Radiant Ventures Taps Virender Ahluwalia As New CFO Radiant Ventures Inc. confirmed it has appointed Virender Ahluwalia as its new Chief Financial Officer. Having over...
-
Vireo's Revenue Spikes 34% In Cannabis Company's 'Strongest Quarter Of Growth'
Tuesday, June 16, 2020 - 2:36pm | 441Medical cannabis company Vireo Health International Inc. (CNSX: VREO) (OTCQX: VREOF) released first-quarter financial results Tuesday, with revenue of $12.1 million. That's a sequential increase of 34% and a year-over-year increase of 110%. Founder and CEO...
-
Vireo Health Posts 62% Year-Over-Year Revenue Growth, Higher Net Loss
Thursday, May 14, 2020 - 11:48am | 410Cannabis company Vireo Health International, Inc. (CNSX: VREO, OTCQX: VREOF) released Thursday its fourth-quarter and fiscal year results for the period concluded Dec. 31, 2019 Vireo's 2019 Business Update Fiscal year 2019 saw revenue growth of 62% on a year-over-year basis, reaching...
-
Vireo Health Expands Partnership With Leaf Trade To 4 States
Wednesday, January 29, 2020 - 11:10am | 278Cannabis company Vireo Health International, Inc. (CNSX:VREO) (OTC: VREOF) announced Tuesday the expansion of its collaboration with Leaf Trade in order to enable a wholesale order and fulfillment management platform in four states. As Vireo plans to extend its services across the nation, Leaf...
-
Low-THC Pre-Rolled Line, Vireo Health's New Bet
Wednesday, January 8, 2020 - 8:52am | 307Vireo Health International Inc (OTC: VREOF), a science-focused cannabis company, on Tuesday announced LiteBud, a line of low-THC products. This new line is focused on consumers that seek a daily product or a controlled high. THC levels will range from 4 to 10%. "Vireo is committed to creating...
-
Federal Prohibition Of Cannabis (Not Vitamin E Acetate) Is The Real Cause Of The Vaping Crisis
Monday, November 18, 2019 - 3:30pm | 875By Bruce Linton and Kyle Kingsley, M.D. The recent wave of vaping-related lung illnesses and fatalities has understandably been a source of concern for millions of cannabis users throughout the United States. Our heartfelt condolences go out to all those that have been harmed by these unsafe...
-
Bruce Linton, Vireo Health CEO Talk Partnership, Next Steps
Friday, November 8, 2019 - 3:33pm | 582On Thursday, Bruce Linton was named executive chairman of multistate operator Vireo Health International Inc (OTC: VREOF). The hiring brings the Canopy Growth Corp (NYSE: CGC) co-founder into the American MSO market. Since his ouster from Canopy, Linton has taken on several advisor, investor...
-
Vireo Health Reports Q2 Revenue Up 70% Year-Over-Year
Thursday, August 29, 2019 - 9:34am | 364Cannabis company Vireo Health International, Inc. (CNSX: VREO) (OTC: VREOF) reported second-quarter total revenue of $7.2 million, up 70% from the same quarter in 2018. The company’s EBITDA and adjusted EBITDA were $0.8 million and $2.3 million, respectively, versus $1.9 million and $2.1...
-
Vireo Health Revenue Increases 57% Year Over Year
Friday, May 31, 2019 - 9:25am | 341U.S. cannabis MSO Vireo Health International, Inc. (CSE: VREO)(OTC: VREOF) first-quarter earnings showed total quarterly revenue of $5.8 million, marking a 57-percent increase year over year. Pro forma revenue for the quarter was roughly $7 million. The company also successfully completed the...
-
Cannabis Execs Pitch Investors In Toronto; iAnthus CFO Says Market Will Grow To Same Magnitude As Alcohol
Friday, April 26, 2019 - 3:24pm | 1155Investors heard from dozens of top cannabis executives April 17-18 at the Benzinga Cannabis Capital Conference in Toronto. Lift & Co Lift & Co Corp (OTC: LFCOF) plans to leverage his company's leadership position as a trade marketing platform in Canada to fuel an...
-
Vireo Health Enters Recreational Cannabis With Mayflower Botanicals Acquisition
Thursday, April 4, 2019 - 1:10pm | 528Vireo Health International (OTC:VREOF), a science-focused multistate cannabis operator, is expanding into Massachusetts through the acquisition of Mayflower Botanicals, one of the state’s registered marijuana dispensaries. Vireo operates in nine states, but Massachusetts will be the...